Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma:...
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
About this item
Full title
Author / Creator
Takahashi, Masanobu , Kato, Ken , Okada, Morihito , Chin, Keisho , Kadowaki, Shigenori , Hamamoto, Yasuo , Doki, Yuichiro , Kubota, Yutaro , Kawakami, Hisato , Ogata, Takashi , Hara, Hiroki , Muto, Manabu , Nakashima, Yuichiro , Ishihara, Ryu , Tsuda, Masahiro , Motoyama, Satoru , Kodani, Mamoru and Kitagawa, Yuko
Publisher
Singapore: Springer Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Singapore
Subjects
More information
Scope and Contents
Contents
Background
The efficacy and safety of nivolumab versus chemotherapy was evaluated in the Japanese subpopulation from the overall intent-to-treat (ITT) population of the ATTRACTION-3 trial conducted in patients with advanced esophageal squamous cell carcinoma (ESCC) as second-line treatment.
Methods
Data from Japanese patients enrolled in t...
Alternative Titles
Full title
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7794205
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7794205
Other Identifiers
ISSN
1612-9059
E-ISSN
1612-9067
DOI
10.1007/s10388-020-00794-x
